市场调查报告书
商品编码
1347593
糖尿病护理设备市场:2023-2028 年全球行业趋势、份额、规模、增长、机会和预测Diabetes Care Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年,全球糖尿病护理设备市场规模达到296亿美元。展望未来,IMARC集团预计到2028年市场规模将达到473亿美元,2023-2028年復合年增长率(CAGR)为7.9%。
糖尿病护理设备是指用于监测或确定血糖水平的设备。智能胰岛素笔、血糖仪、酮、连续血糖监测仪 (CGM)、胰岛素泵和糖尿病管理应用程序是一些常见的糖尿病护理设备。它们由刺血针、葡萄糖传感器、监视器、扩展坞、测试插头和测试条组成,有助于持续监测糖尿病状况。糖尿病护理设备广泛用于诊断和监测糖尿病,这是一种影响血液中葡萄糖吸收量的慢性疾病。因此,这些设备有助于准确识别血糖水平,确定糖尿病治疗的有效性,并降低高血糖和低血糖的发生率。
糖尿病患病率不断上升,特别是在全球范围内稳步增长的老年人口中,正在为市场创造积极的前景。糖尿病护理设备被广泛用于治疗和管理与该疾病相关的症状和并发症,例如呼吸问题、肾衰竭和肝衰竭以及心血管疾病。与此相一致的是,为了更好地护理和管理疾病而广泛使用血糖监测和胰岛素输送设备有利于市场增长。除此之外,集成人工智能(AI)、机器学习(ML)和物联网(IoT)的智能糖尿病设备的推出,可以远程监控患者的症状和生物标誌物,这也为市场增长提供了动力。此外,对自我血糖监测(SMBG)的需求不断增长,其中包括有关患者动态血糖概况的信息,这对市场增长产生了积极影响。阅读进一步有助于适当安排食物、活动和药物,从而使它们成为治疗糖尿病的有价值的工具。其他因素,包括广泛的研发(R&D)活动、不断变化的饮食习惯和久坐的生活方式,以及旨在提供更好健康服务的各种政府倡议的实施,预计将推动市场增长。
The global diabetes care devices market size reached US$ 29.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 47.3 Billion by 2028, exhibiting a growth rate (CAGR) of 7.9% during 2023-2028.
Diabetes care devices refer to equipment used to monitor or determine blood sugar levels. Smart insulin pens, glucometers, ketone, continuous glucose monitors (CGMs), insulin pumps and diabetes management applications are some of the common diabetes care devices. They consist of lancets, glucose sensors, monitors, docking stations, test plugs and test strips that help constantly monitor diabetic conditions. Diabetes care devices are widely used to diagnose and monitor diabetes mellitus, a chronic disorder that affects the amount of glucose absorption in the blood. Consequently, these devices assist in accurately identifying blood sugar levels, determining the effectiveness of diabetes treatment, and lowering the instances of hyperglycemia and hypoglycemia.
The growing prevalence of diabetes, especially amongst the steadily rising geriatric population across the globe, is creating a positive outlook for the market. Diabetes care devices are widely adopted to treat and manage symptoms and complications associated with the disorder, such as respiratory issues, kidney and liver failure, and cardiovascular conditions. In line with this, the extensive utilization of glucose monitoring and insulin delivery devices for better care and management of the disease is favoring the market growth. Apart from this, the introduction of smart diabetes devices integrated with artificial intelligence (AI), machine learning (ML) and the Internet of Things (IoT) to enable remote monitoring of the patient's symptoms and biomarkers are providing an impetus to the market growth. Additionally, the increasing demand for self-monitoring of blood glucose (SMBG) that includes information regarding the patient's dynamic blood glucose profile is positively impacting the market growth. The reading further aids in the appropriate scheduling of food, activity, and medication, thus making them a valueable tool in the treatment of diabetes mellitus. Other factors, including extensive research and development (R&D) activities, evolving eating habits and sedentary lifestyles, and the implementation of various government initiatives focusing on providing better health services are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global diabetes care devices market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, distribution channel and end user.
Blood Glucose Monitoring (BGM) Devices
Self-Monitoring Devices
Continuous Glucose Monitoring Devices
Insulin Delivery Devices
Pumps
Pens
Syringes
Jet Injectors
Hospital Pharmacies
Retail Pharmacies
Diabetes Clinics/Centers
Online Pharmacies
Others
Hospitals
Homecare
Diagnostic Centers
Ambulatory Surgery Centers
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, ACON Laboratories Inc., Ascensia Diabetes Care Holdings AG (PHC Holdings Corporation), Becton Dickinson and Company, Bionime Corporation, Dexcom Inc., F. Hoffmann-La Roche AG, Johnson & Johnson, Medtronic plc, Novo Nordisk A/S, Sinocare Inc. and Terumo Corporation.